CytRx Market and Forecasts, May 2013

You might be interested in: clinical trial, cancer, drug discovery, more »


 

» Download Public Reports

1-3 of 3 reports for CytRx
Drug Discovery Market Statistics

Drug Discovery Market Statistics

  • Industry report
  • January 2011
  • 8 pages

... North america 164 europe 164 japan 164 rest of the world 164 competitive structure 165 market share analysis 166 ambion 168 alnylam pharmaceuticals, inc. 168 Benitec ltd 169 cytrx corp. 170 ...

Drug and Medication Sector in The United States

Drug and Medication Sector in The United States

  • Industry report
  • June 2012
  • 23 pages
  • by Corporation

... Business officer President at zelos, chief business officer at cytrx, pdl, facet Vp at bms & global business leader at roche ahmet tutuncu, md, phd svp & chief medical officer Vp medical ...

Drug Sector in Japan

Drug Sector in Japan

  • Industry report
  • June 2012
  • 3 pages

... Licensed-out to: cytrx corporation (usa) preparation preparation hematologic malignancies hematologic malignancies potent inhibitor of bcr-abl and lyn tyrosine kinases. Possibly ef_fective in imatinib ...



Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.